These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7786033)

  • 1. Purification and characterization of tubulin from parental and vincristine-resistant HOB1 lymphoma cells.
    Lee WP
    Arch Biochem Biophys; 1995 Jun; 319(2):498-503. PubMed ID: 7786033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification, cDNA cloning, and expression of human sorcin in vincristine-resistant HOB1 lymphoma cell lines.
    Lee WP
    Arch Biochem Biophys; 1996 Jan; 325(2):217-26. PubMed ID: 8561500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered molecular properties of tubulin in a multidrug-resistant variant of Chinese hamster cells selected for resistance to vinca alkaloids.
    Pain J; Sirotnak FM; Barrueco JR; Yang CH; Biedler JL
    J Cell Physiol; 1988 Aug; 136(2):341-7. PubMed ID: 3045133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and molecular cloning of human sorcin a calcium-binding protein in vincristine-resistant HOB1 lymphoma cells.
    Wang SL; Tam MF; Ho YS; Pai SH; Kao MC
    Biochim Biophys Acta; 1995 Feb; 1260(3):285-93. PubMed ID: 7873602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein is hyperphosphorylated in multidrug resistant HOB1 lymphoma cells treated with overdose of vincristine.
    Lee WP
    Biochim Biophys Acta; 1995 Aug; 1245(1):57-61. PubMed ID: 7654766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of reduced growth rate in the development of drug resistance of HOB1 lymphoma cells to vincristine.
    Lee WP
    Cancer Lett; 1993 Sep; 73(2-3):105-11. PubMed ID: 8221621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug resistant HOB1 lymphoma cells express P-glycoprotein that does not play the major role in the development of drug resistance to adriamycin.
    Lee WP; Lee CL; Kao MC
    Biochem Biophys Res Commun; 1992 Nov; 189(1):92-100. PubMed ID: 1360209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of vincristine-resistant HOB1 lymphoma cell line showing the classical MDR phenotype and altered expression of membrane glycoproteins.
    Lee WP; Lee CL
    Oncology; 1994; 51(1):2-8. PubMed ID: 7903440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins.
    Houghton JA; Houghton PJ; Hazelton BJ; Douglass EC
    Cancer Res; 1985 Jun; 45(6):2706-12. PubMed ID: 3986804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markedly decreased binding of vincristine to tubulin in vinca alkaloid-resistant Chinese hamster cells is associated with selective overexpression of alpha and beta tubulin isoforms.
    Sirotnak FM; Danenberg KD; Chen J; Fritz F; Danenberg PV
    Biochem Biophys Res Commun; 2000 Mar; 269(1):21-4. PubMed ID: 10694470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markedly altered membrane transport and intracellular binding of vincristine in multidrug-resistant Chinese hamster cells selected for resistance to vinca alkaloids.
    Sirotnak FM; Yang CH; Mines LS; Oribé E; Biedler JL
    J Cell Physiol; 1986 Feb; 126(2):266-74. PubMed ID: 3944208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct analysis of tubulin expression in cancer cell lines by electrospray ionization mass spectrometry.
    Verdier-Pinard P; Wang F; Burd B; Angeletti RH; Horwitz SB; Orr GA
    Biochemistry; 2003 Oct; 42(41):12019-27. PubMed ID: 14556633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cytoskeletal inhibitors on the accumulation of vincristine in a resistant human lung cancer cell line with high level of polymerized tubulin.
    Chan MW; Chiang CD; Song EJ; Yang VC
    Cancer Biochem Biophys; 1998 Nov; 16(4):347-63. PubMed ID: 9925282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of vinca alkaloids with tubulin: a comparison of vinblastine, vincristine, and vinorelbine.
    Lobert S; Vulevic B; Correia JJ
    Biochemistry; 1996 May; 35(21):6806-14. PubMed ID: 8639632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
    Kumar A; Soprano DR; Parekh HK
    Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Tubulin mutations are associated with resistance to 2-methoxyestradiol in MDA-MB-435 cancer cells.
    Gökmen-Polar Y; Escuin D; Walls CD; Soule SE; Wang Y; Sanders KL; Lavallee TM; Wang M; Guenther BD; Giannakakou P; Sledge GW
    Cancer Res; 2005 Oct; 65(20):9406-14. PubMed ID: 16230404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity.
    Gan PP; Kavallaris M
    Cancer Res; 2008 Dec; 68(23):9817-24. PubMed ID: 19047161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
    Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
    Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
    Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.
    Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K
    Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.